Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes inflammation, pain, and stiffness in the joints. But RA is a systemic disease — it affects the whole body — and can ...
This has changed with the development of TNF-α inhibitors that are used effectively to treat AS and arrest progression of peripheral arthritis in other SpA. [7] A major challenge over recent ...
Samples were from 44 participants with Crohn's disease without joint inflammation, 39 with Crohn's disease and peripheral spondyloarthritis, 14 with Crohn's and axial spondyloarthritis ...
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery ...
Nearly 1.7 million State Pensioners across Great Britain are set to receive as much as £5,740 a year more from April. The ...
According to the Crohn’s & Colitis Foundation, as many as 30% of people living with IBD also have some form of arthritis, such as peripheral arthritis, which commonly affects large joints in the ...
11d
News Medical on MSNLeveraging data science for disease prediction in the fight against rheumatoid arthritisFan Zhang, PhD, of the University of Colorado Department of Medicine sees artificial intelligence as a pathway to combating an intractable enemy: rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results